|
Dr. Giuliano currently serves as a Principal Scientist at Cellumen, Inc. where he is involved in the development and integration of new cell-based reagents and multiplexed HCS assays. Dr. Giuliano was formerly a Principal Scientist at Cellomics. He was also an Assistant Professor in the Departments of Neurological Surgery and Cell Biology and Physiology at the University of Pittsburgh Cancer Institute. He has authored more than 40 papers on the creation and use of advanced, fluorescence-based reagents and High Content Screening. Dr. Giuliano has authored or co-authored 15 patents. Dr. Giuliano received his Ph.D. in Biochemistry from Colorado State University. | 